Skip to main content
. 2014 Apr 18;73(6):1253–1261. doi: 10.1007/s00280-014-2461-5

Table 3.

Percentages of patients who required dose reduction and those who discontinued treatment during 1–5 courses of treatment (6 months)

Control group (n = 531) (%) Study group (n = 532) (%) Total (n = 1,052) (%)
Dose reduction
 (−) 84.7 90.2 87.5
 (+) 15.3 9.8 12.5
Treatment discontinuation
 (−) 64.0 66.4 65.2
 (+) 36.0 33.6 34.8